Vivek Reddy, MD
Clinical Cardiac Electrophysiology · New York, NYNPI 1083672463
Payments from drug & device makers
What this record shows
This record is dominated by other: $13,758,164 of the $14,901,388 with a category attached, or 92.3%. Medtronic accounts for 69.2% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2022 at $8,646,794 and has fallen 82.0% since, to $1,557,291 in 2025. Among clinical cardiac electrophysiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 524 payments — averaging $28,438 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$10.3M
- Boston Scientific$3.6M
- Johnson & Johnson$276K
- Biosense Webster, Inc.$198K
- Abbott$94K
- Circa Scientific, Inc.$88K
- plus $294K from 23 others
Across 27 payments — averaging $63,931 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Recor Medical Inc$921K
- Boston Scientific$369K
- Biosense Webster, Inc.$284K
- Abbott$151K
Across 7 payments — averaging $15,690 each. An ownership or investment interest held by the physician or an immediate family member.
- Anumana, Inc.$110K
- Manual Surgical Sciences, LLC$0
What the payments were for
- Royalty or licence$2,2910%
- Consulting fees$609,5064%
- Speaking & faculty fees$201,5981%
- Grants$11,6390%
- Travel & lodging$201,0341%
- Food & beverage$22,1420%
- Education$1810%
- Ownership interest$94,8341%
- Other$13,758,16492%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 56 | $10,306,525 |
| Boston Scientific | 196 | $3,643,899 |
| Johnson & Johnson(2 entities) | 5 | $276,039 |
| Biosense Webster, Inc. | 25 | $198,454 |
| Abbott | 130 | $94,346 |
| Circa Scientific, Inc. | 2 | $87,900 |
| Adagio Medical, Inc. | 15 | $73,617 |
| Substrate HD | 1 | $72,158 |
| Acutus Medical, Inc. | 17 | $67,462 |
| Pulse Biosciences, Inc. | 14 | $42,000 |
| Medical Device Business Services, Inc. | 6 | $9,814 |
| Biotronik Inc. | 9 | $8,540 |
| Impulse Dynamics (USA) Inc. | 9 | $8,009 |
| Novo Nordisk AS | 1 | $3,750 |
| Cardiofocus, Inc. | 5 | $2,885 |
| Anumana, Inc. | 1 | $2,291 |
| Recor Medical Inc | 5 | $1,895 |
| Ancora Heart, Inc. | 5 | $894 |
| Philips North America LLC | 2 | $210 |
| Cardiva Medical, Inc. | 6 | $188 |
| Ablacon, Inc. | 2 | $181 |
| United Therapeutics Corporation | 1 | $104 |
| Atricure, Inc. | 2 | $61 |
| Novartis | 4 | $55 |
| Serpex Medical Inc | 1 | $25 |
| Cordis US CORP. | 1 | $24 |
| Irhythm Technologies, Inc. | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Novo Nordisk | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL EP$1,977,967
- GENERAL - THERAPIES$1,513,654
- Farapulse$73,406
- Volta AF-Xplorer$72,158
- AVEIR$44,806
- CellFX$42,000
- Carto 3$22,151
- WATCHMAN Access System$16,643
- OPTIMIZER$15,705
- GENERAL - STRUCTURAL HEART$13,693
- AMPLATZER AMULET$10,527
- AMPLATZER Occluders$8,932
- Thermocool SF$5,961
- Micra$4,856
- WATCHMAN FLX$3,282
- ARCTIC FRONT ADVANCE$2,550
- Arctic Front$2,450
- Paradise Ultrasound Renal Denervation System$1,895
- MitraClip$1,849
- Acticor 7 VR-T DX$1,566
How this compares
$14,901,388 in reported general payments places this provider in the 95th percentile of 214 clinical cardiac electrophysiology providers in New York.
See all clinical cardiac electrophysiology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 65 | $57,838 |
| XareltoRivaroxaban | 27 | $26,935 |
| MultaqDronedarone Hcl | 19 | $24,877 |
| Colchicine | 72 | $3,463 |
| Metoprolol Succinate | 39 | $420 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 13 | $368 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $276,039 | $26,93527 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 214 clinical cardiac electrophysiology providers in New York.
Other clinical cardiac electrophysiology in New York
- Jacob KoruthNew York$3.7M
- Srinivas DukkipatiNew York$2.7M
- Amir AhmadiNew York$789K
- Larry ChinitzNew York$448K
- James IpNew York$347K
- Nicholas SkipitarisNew York$293K
- Mohit TuragamNew York$202K
- David LauNew York$202K
- Christopher LiuNew York$181K
- Chirag BarbhaiyaNew York$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.